Detail
LncRNA Name | DLX6-AS1 |
Synonyms | DLX6-AS1, DLX6-AS, DLX6AS, Evf-2, NCRNA00212, FLJ34048 |
Region | GRCh38_7:96955141-97014065 Sequence |
Ensembl | ENSG00000231764 |
RefSeq | NR_015448 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | renal cell carcinoma |
ICD-0-3 | C64.9 |
Methods | qPCR, Western blot, RIP, Luciferase reporter assays etc. |
Sample | renal cell carcinoma tumors, cell lines (A498, ACHN, Caki-1, Caki2, 786-O and G401) |
Expression Pattern | up-regulated |
Function Description | In this study, we identified an upregulated lncRNA, DLX6-AS1, in RCC tumor tissues compared with normal kidney tissues. Our data suggested that DLX6-AS1 promoted RCC cell growth and tumorigenesis via targeting miR-26a. |
Pubmed ID | 28881158 |
Year | 2017 |
Title | Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis |
External Links |
Links for DLX6-AS1 | GenBank HGNC lncrnadb Noncode |
Links for renal cell carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.